MITOCHONDRIAL ENCEPHALOMYOPATHY LACTIC ACIDOSIS AND STROKE-LIKE EPISODES MELAS MUTATION DETECTION Test
Test Name: MITOCHONDRIAL ENCEPHALOMYOPATHY LACTIC ACIDOSIS AND STROKE-LIKE EPISODES MELAS MUTATION DETECTION Test
Test Components: PCR, Sequencing
Price: 1290.0 AED
Sample Condition: 4 mL (2 mL min.) whole blood in 1 Lavender top (EDTA) tube. Ship refrigerated. DO NOT FREEZE. Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory.
Report Delivery: Sample Mon by 9 am; Report Fri
Test Type: Disorders of Nervous System, Genetic diseases
Doctor: Neurologist
Test Department: MOLECULAR DIAGNOSTICS
Pre Test Information: Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory.
Test Details
The Mitochondrial Encephalomyopathy Lactic Acidosis and Stroke-like Episodes (MELAS) Mutation Detection Test is a genetic test used to identify mutations in the mitochondrial DNA that are associated with MELAS syndrome. MELAS is a rare genetic disorder that affects the energy production in cells, leading to various symptoms including muscle weakness, stroke-like episodes, seizures, and lactic acidosis.
The test involves analyzing a blood or tissue sample to identify specific mutations in the mitochondrial DNA. These mutations are known to be associated with MELAS syndrome. The test can help confirm a diagnosis of MELAS and provide information about the specific genetic mutation present in an individual.
Genetic testing for MELAS can be useful for individuals with suspected MELAS syndrome, as well as for family members who may be at risk of inheriting the condition. It can also help guide treatment decisions and provide information about the prognosis and potential complications associated with MELAS.
It is important to note that genetic testing for MELAS is typically performed in specialized laboratories and requires a referral from a healthcare provider. Genetic counseling is also recommended before and after testing to help individuals understand the implications of the test results and make informed decisions about their healthcare.
| Test Name | MITOCHONDRIAL ENCEPHALOMYOPATHY LACTIC ACIDOSIS AND STROKE-LIKE EPISODES MELAS MUTATION DETECTION Test |
|---|---|
| Components | |
| Price | 1290.0 AED |
| Sample Condition | 4 mL (2 mL min.) whole blood in 1 Lavender top (EDTA) tube. Ship refrigerated. DO NOT FREEZE. Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory. |
| Report Delivery | Sample Mon by 9 am; Report Fri |
| Method | PCR, Sequencing |
| Test type | Disorders of Nervous System, Genetic diseases |
| Doctor | Neurologist |
| Test Department: | MOLECULAR DIAGNOSTICS |
| Pre Test Information | Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory. |
| Test Details |
The Mitochondrial Encephalomyopathy Lactic Acidosis and Stroke-like Episodes (MELAS) Mutation Detection Test is a genetic test used to identify mutations in the mitochondrial DNA that are associated with MELAS syndrome. MELAS is a rare genetic disorder that affects the energy production in cells, leading to various symptoms including muscle weakness, stroke-like episodes, seizures, and lactic acidosis. The test involves analyzing a blood or tissue sample to identify specific mutations in the mitochondrial DNA. These mutations are known to be associated with MELAS syndrome. The test can help confirm a diagnosis of MELAS and provide information about the specific genetic mutation present in an individual. Genetic testing for MELAS can be useful for individuals with suspected MELAS syndrome, as well as for family members who may be at risk of inheriting the condition. It can also help guide treatment decisions and provide information about the prognosis and potential complications associated with MELAS. It is important to note that genetic testing for MELAS is typically performed in specialized laboratories and requires a referral from a healthcare provider. Genetic counseling is also recommended before and after testing to help individuals understand the implications of the test results and make informed decisions about their healthcare. |
